Trial Profile
A Prospective Clinical Observation Study to Evaluate the Influence of Long Term Treatment of Pitavastatin on the Therapeutic Prognosis and Safety in Acute Myocardial Infarction.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Pitavastatin (Primary)
- Indications Hyperlipidaemia; Myocardial infarction
- Focus Therapeutic Use
- Acronyms LAMIS; PTV-KAMI
- Sponsors JW Pharmaceutical
- 29 Mar 2012 Actual end date (Mar 2011) added as reported by ClinicalTrials.gov.
- 15 Dec 2008 New trial record.